Cepheid GeneXpert reagents

This pre-solicitation notice seeks reagents for panel testing on Cepheid GeneXpert instruments owned by the government. The Department of the Army Medical Command requires compatible reagents to conduct respiratory panels for TB, MRSA, Group B Strep, C. difficile, carbapenem resistance, influenza, RSV, SARS and COVID at Dwight David Eisenhower Army Medical Center. The contractor must provide reagents on an as-needed basis over a five year period from a base year and four option years. The reagents must be capable of producing diagnostic results within two hours for the listed respiratory panels. The due date for responses is April 8, 2022.

There is no set-aside designated for this requirement. The solicitation number is W91YTZ22Q0014 and is estimated to have a total value of over $3 million based on the annual quantities and pricing provided in the attached spreadsheet. Reagents will be needed to test between 5,000 to 15,000 samples annually depending on the specific panel. The contractor must be able to provide the reagents within 72 hours of order on an as-needed basis throughout the five year period.